source
- FDA urged to boost US access to new and experimental drugs as trials shift to ChinaThe piece highlights that the FDA has taken steps such as launching Operation TrialBlazer and tightening review of foreign clinical data, but argues that further action is required to keep the Unit…
- Shionogi to acquire Texas-based IntraBio for $2 billion, adding marketed rare-disease drug AqneursaShionogi announced Monday it will buy IntraBio, a Texas biotech, for $2 billion in cash, making IntraBio a wholly owned subsidiary of its U.S. division. The deal gives Shionogi ownership of Aqneur…